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The proposal has two parts. The first-annual appraisal-is uncontroversial; it can be helpful. 2 The second is a summative assessment every five years, aggregating the appraisals, which is reviewed by two doctors from the appraisee's field and a lay person; collectively they determine whether to recommend revalidation. This does not lead to de-registration: it acts as a sieve, seeking to identify potentially inadequate doctors, who would then undergo further assessment under the performance procedures devised by Southgate et al. 3 It is the sieve that is inappropriate.
One difficulty in assessment is making it fair between candidates. In examinations, this requires minimisation of interexaminee variables-for example, the same assessors judge the same attributes of all candidates-and thorough training of assessors. The General Medical Council proposes an individual group of assessors for each doctor's review. The levels of judgment of the assessors will differ considerably, each group being different. Serious training for all assessors for the thousands of candidates assessed annually (extraordinarily, the council cannot indicate numbers) seems improbable: an assessment of osteopaths' portfolios required up to three days' training for assessors (B Jolly, personal communication) .
Portfolio assessment has good face validity and may be useful when used formatively.
2 Few evaluations have been conducted of it; research in the medical field suggests that it is subject to assessor bias and is unreliable and inaccurate. 4 Estimates of the time needed for the review (involving three assessors examining five-year portfolios and interviewing the appraisee; say five days for each professional to consider the submission, interview, and report and five days' preparation for the appraisee) suggest a cost of at least £50m a year, or an opportunity cost of around 1% of clinicians' time. This is an enormous expense to identify, inaccurately, those doctors to subject to further assessment.
Peer associate ratings, used in the United States, 5 could be quicker and more accurate but might be inappropriate for some groups -for example, singlehanded general practitioners. But one could readily devise a paper based assessment exercise of a maximum one day's duration as a sieve towards the performance procedures. 
BMA approves acupuncture

BMA report is wrong
Editor-The BMA report on acupuncture is regrettable. It suggests, among other things, that acupuncture is effective for back pain, dental pain, and migraine. Three recent systematic reviews show the importance of basing judgments on high quality information. For back pain, four randomised and blind studies showed no benefit; five open studies showed benefit.
1 The BMA's conclusion that acupuncture was effective in back pain was based on all nine studies.
For dental pain, a review of 16 studies concluded that it was effective.
2 Many of these were not randomised, were not blind, or had major flaws. Only three small studies were adequate, and these showed no convincing benefit.
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For migraine, trials showing a significant benefit from acupuncture were inadequately randomised or not blind. 4 The reviewers themselves were highly circumspect about ascribing any clinical significance to acupuncture.
The BMA report concluded that results for acupuncture are inconclusive in other conditions. These are weasel words. For smoking cessation the 12 month cessation rate with acupuncture was 14% (95% confidence interval 11% to 17%), which was no different from the placebo response with nicotine gum of 12% (11% to 13%).
Trials of acupuncture suffer problems of poor quality, which leads to bias. Reviews with poor quality studies overestimate treatment effects. Original reports may come to the wrong conclusion from their own data, a fact true of two of 13 studies of acupuncture in neck and back pain. 
